Support for model-informed drug development continues to grow in the regulatory arena. Learn how MIDD has evolved and what’s coming next.
This is a two part session. The second part will resume at 12:30 p.m.
ATTENTION: LIMITED SEATING AVAILABLE. To participate in this user group meeting, you must be a licensed user of Certara’s software. Register with Certara at http://lp.certara.com/Phoenix-UGM_Washington-DC_Registration.html by November 2 to reserve your seat.